Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126015641 | 12601564 | 1 | I | 20150203 | 20160728 | 20160728 | EXP | CA-JAZZ-2015-CA-022895 | JAZZ | 11.00 | YR | M | Y | 0.00000 | 20160728 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126015641 | 12601564 | 1 | PS | Asparaginase | ASPARAGINASE | 1 | UNK | U | 125359 | INJECTION | |||||||||
126015641 | 12601564 | 2 | SS | Doxorubicin | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | INJECTION | ||||||||
126015641 | 12601564 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | U | 0 | |||||||||
126015641 | 12601564 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | 0 | |||||||||
126015641 | 12601564 | 5 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126015641 | 12601564 | 1 | Acute lymphocytic leukaemia |
126015641 | 12601564 | 2 | Acute lymphocytic leukaemia |
126015641 | 12601564 | 3 | Acute lymphocytic leukaemia |
126015641 | 12601564 | 4 | Acute lymphocytic leukaemia |
126015641 | 12601564 | 5 | Acute lymphocytic leukaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126015641 | 12601564 | HO |
126015641 | 12601564 | OT |
126015641 | 12601564 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126015641 | 12601564 | Abscess fungal | |
126015641 | 12601564 | Alanine aminotransferase increased | |
126015641 | 12601564 | Aspartate aminotransferase increased | |
126015641 | 12601564 | Atelectasis | |
126015641 | 12601564 | Body temperature increased | |
126015641 | 12601564 | Hepatosplenomegaly | |
126015641 | 12601564 | Hypoxia | |
126015641 | 12601564 | Liver abscess | |
126015641 | 12601564 | Lung infiltration | |
126015641 | 12601564 | Mucosal inflammation | |
126015641 | 12601564 | Multiple organ dysfunction syndrome | |
126015641 | 12601564 | Neutropenia | |
126015641 | 12601564 | Pulmonary alveolar haemorrhage | |
126015641 | 12601564 | Renal abscess | |
126015641 | 12601564 | Respiratory distress | |
126015641 | 12601564 | Streptococcal infection | |
126015641 | 12601564 | Trichosporon infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |